Optimizing Cell & Gene Therapy Processes Archives - Pharmaceutical Technology https://www.pharmaceutical-technology.com/sector/partners/optimizing-cell-gene-therapy-processes/ The leading site for news and procurement in the pharmaceutical industry Tue, 16 Apr 2024 16:27:27 +0000 en-US hourly 1 https://wordpress.org/?v=6.4.2 https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2022/01/cropped-Pharmaceutical-Technology-Favicon-150x150.png Optimizing Cell & Gene Therapy Processes Archives - Pharmaceutical Technology https://www.pharmaceutical-technology.com/sector/partners/optimizing-cell-gene-therapy-processes/ 32 32 Harnessing the power of cell and gene therapy in oncology https://www.pharmaceutical-technology.com/sponsored/harnessing-the-power-of-cell-and-gene-therapy-in-oncology/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/04/cell-and-gene-therapy-1.jpg Tue, 16 Apr 2024 16:23:46 +0000 https://www.pharmaceutical-technology.com/sponsored/harnessing-the-power-of-cell-and-gene-therapy-in-oncology/

]]> Quality versus quantity in T-cell production: Why it doesn’t have to be a trade-off https://www.pharmaceutical-technology.com/sponsored/quality-versus-quantity-in-t-cell-production-why-it-doesnt-have-to-be-a-trade-off/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/03/T-cells_1092921812.jpg Wed, 13 Mar 2024 10:36:49 +0000 https://www.pharmaceutical-technology.com/sponsored/quality-versus-quantity-in-t-cell-production-why-it-doesnt-have-to-be-a-trade-off/ Experts believe gene therapy offers potential to impact Gaucher disease market https://www.pharmaceutical-technology.com/analyst-comment/experts-gene-therapy-potential-impact-gaucher-disease-market/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2023/11/shutterstock_1869651874-1.jpg Tue, 21 Nov 2023 16:12:58 +0000 https://www.pharmaceutical-technology.com/comment/experts-gene-therapy-potential-impact-gaucher-disease-market/